Endocrine Research Updates

For Medical Professionals

Clinical Practice for Iodine Supplementation during Preconception, Pregnancy, and Lactation Lags Behind Medical Society Recommendations
Iodine supplementation for women of childbearing age, pregnancy and breastfeeding is recommended but 3 in 4 practitioners do not followed the prescribed recommendations.
Non-Invasive Imaging may reduce need for removal of benign thyroid nodules.
Using FDG-PET in combination with sonographic features may improve diagnosis of indeterminate thyroid nodules that are benign, aiming for fewer surgeries.
Researchers found that Sitagliptin and Metformin therapy may prevent hyperglycemic relapses in obese African Americans
Treatment with pioglitazone, a thiazolidinedione, acts as a preventive agent in individuals with insulin sensitivity who are at elevated risk for cardiovascular disease.
Results may needlessly worry some, researcher says; others call it an urgent need to alert Americans early and get them the medical care necessary to avoid costly care later
Despite the known efficacy and value, the range of available weight loss medications remain underutilized and inadequately prescribed
Scientific consensus demands action to protect the public from the known adverse impact of commonly occurring, endocrine-disrupting chemicals (EDCs) found in the environment.
new weight loss device prompts sustained weight loss
Reduced comorbid risk factors and improved satiety reported with minimal side effects, using the first new obesity therapy to receive FDA device approval in 9 years
Hyperthyroid Guidelines
Expert task force revises the 5-year old clinical care guidelines to reflect critical advances in patient management
diabetes extra income
AADE superstars share their strategies for creating alternative revenue streams
Two top diabetes educators offer strategies for CDEs to earn more income.
Elderly female receiving an injection from the Doctor
With Paul Miller, MD, Anne R. Cappola, MD, ScM, and Dolores M. Shoback, MD
Daily injection of the synthetic peptide abaloparatide for 18 months significantly reduced the risk of new vertebral and nonvertebral fractures in postmenopausal women with osteoporosis at high risk of fracture.
Close-up of patient hands measuring glucose level blood test with glucomete
Lead Author Matthew J. O’Brien, MD and Priyathama Vellanki, MD Comment
The detection of dysglycemia was found to be lower among racial/ethnic minorities using the new 2015 United States Preventive Services Task Force prediabetes and diabetes screening guidelines.
Stack of colorful magazines against a white background
Lead author David S. Cooper, MD and John C. Morris, III, MD Comment
Research in the field of thyroid disease is thriving with a third of all papers on this topic being published in the last 10 years, according to an analysis in the August issue of Thyroid.
Woman having an ultrasound test performed on the thyroid
Senior Author Julie A. Sosa, MD and Robert C. Smallridge, MD comment
While patients with pT1a and pT1b differentiated thyroid cancer underwent different treatment strategies during the last decade, survival outcomes were similar, according to a retrospective analysis in the August issue of Thyroid.
Young boy having his blood drawn for testing
Task Force vice chair David Grossman, MD, MPH; Douglas K. Owens, MD, MS; and, Robert H. Eckel, MD provide comments
The U.S. Preventive Services Task Force (USPSTF) reviewed evidence for screening asymptomatic children and adolescents for both familial hypercholesterolemia and multifactorial dyslipidemia.
black male patient with his doctor
With commentary by Chih-Lung Lin, PhD and Natan Bar-Chama, MD
Men with erectile dysfunction (ED) are at increased risk for osteoporosis and should undergo bone density screening, according to findings from a large study reported in Medicine.
Vemurafenib chemical structure
Lead author Marcia Brose, MD, PhD and Gregory A. Masters, MD, FASCO (American Society Clinical Oncology, ASCO Expert) Comment
The targeted therapy with vemurafenib led to partial responses in at least one-third of patients with metastatic thyroid cancer harboring a BRAF mutation, according to an open-label phase 2 clinical study published online ahead of print in Lancet Oncology.
Cancer word on wooden blocks
Comments by lead author Sogol Mostoufi-Moab, MD, MSCE and expert commentary provided by Melissa M. Hudson, MD.
Childhood cancer survivors are at increased risk for endocrine disorders into adulthood, with the cumulative incidence and prevalence increasing over time.
blue eye, erasing the tear away
Commentary by Senior Author, Professor Geoffrey Reed; Lead Investigator, Rebeca Robles, PhD; and, Griet De Cuypere, MD, PhD
New evidence supports removing the diagnosis of transgender from the WHO International Classification of Diseases, according to a study published in The Lancet Psychiatry.
Doctor overloaded at work sitting at computer
Lead Author, Tait Shanafelt, MD and EndocrineWeb Editorial Board Member Caroline Apovian, MD Comment
New findings link physician dissatisfaction and professional burnout to use of electronic health records (EHRs) and computerized physician order entry (CPOE), according to large nationwide study published in the July issue of Mayo Clinic Proceedings.